Takeshi Susukida

Sugitani, 9300194, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Preferential Recognition of Drug-Induced Altered Self-Presentation on Tumor Cells, but Not Host Cells, by CD8+ T Cells for Eliciting Anti-Tumor Immunity.

Preferential Recognition of Drug-Induced Altered Self-Presentation on Tumor Cells, but Not Host Cells, by CD8+ T Cells for Eliciting Anti-Tumor Immunity.

Journal: Biological & pharmaceutical bulletin

Published: October 22, 2025

Juzentaihoto modulates gut microbiota and potentiates the anti-tumor effect of anti-PD-1 antibody in an immunogenic mouse melanoma model.

Juzentaihoto modulates gut microbiota and potentiates the anti-tumor effect of anti-PD-1 antibody in an immunogenic mouse melanoma model.

Journal: Journal of natural medicines

Published: July 22, 2025

Glycolytic metabolism of CD8+ T-cells affects susceptibility to human leukocyte antigen-mediated abacavir-induced hypersensitivity.

Glycolytic metabolism of CD8+ T-cells affects susceptibility to human leukocyte antigen-mediated abacavir-induced hypersensitivity.

Journal: British journal of pharmacology

Published: May 17, 2025

HLA-B*57:01-dependent intracellular stress in keratinocytes triggers dermal hypersensitivity reactions to abacavir.

HLA-B*57:01-dependent intracellular stress in keratinocytes triggers dermal hypersensitivity reactions to abacavir.

Journal: PNAS nexus

Published: March 07, 2024

Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.

Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.

Journal: Cells

Published: July 16, 2023

Calorie Restriction Impairs Anti-Tumor Immune Responses in an Immunogenic Preclinical Cancer Model.

Calorie Restriction Impairs Anti-Tumor Immune Responses in an Immunogenic Preclinical Cancer Model.

Journal: Nutrients

Published: July 12, 2023

Drug-induced altered self-presentation increases tumor immunogenicity.

Drug-induced altered self-presentation increases tumor immunogenicity.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 08, 2023

DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.

DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.

Journal: Cells

Published: March 05, 2023

The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice.

The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice.

Journal: Toxicology

Published: September 03, 2021

Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity.

Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity.

Journal: Communications biology

Published: November 19, 2020

HLA transgenic mice: application in reproducing idiosyncratic drug toxicity.

HLA transgenic mice: application in reproducing idiosyncratic drug toxicity.

Journal: Drug metabolism reviews

Published: August 28, 2020

Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.

Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.

Journal: Toxicology and applied pharmacology

Published: December 25, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026